These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25816299)

  • 1. Direct medical cost of type 2 diabetes in singapore.
    Shuyu Ng C; Toh MP; Ko Y; Yu-Chia Lee J
    PLoS One; 2015; 10(3):e0122795. PubMed ID: 25816299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large impact of antidiabetic drug treatment and hospitalizations on economic burden of diabetes mellitus in The Netherlands during 2000 to 2004.
    van der Linden MW; Plat AW; Erkens JA; Emneus M; Herings RM
    Value Health; 2009 Sep; 12(6):909-14. PubMed ID: 19508664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical cost of stroke in Singapore.
    Ng CS; Toh MP; Ng J; Ko Y
    Int J Stroke; 2015 Oct; 10 Suppl A100():75-82. PubMed ID: 26179153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do type 2 diabetes mellitus (T2DM)-related complications and socioeconomic factors impact direct medical costs? A cross-sectional study in rural Southeast China.
    Wu H; Eggleston KN; Zhong J; Hu R; Wang C; Xie K; Chen Y; Chen X; Yu M
    BMJ Open; 2018 Nov; 8(11):e020647. PubMed ID: 30389755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of diabetes and its complications in Poland.
    Leśniowska J; Schubert A; Wojna M; Skrzekowska-Baran I; Fedyna M
    Eur J Health Econ; 2014 Jul; 15(6):653-60. PubMed ID: 23820625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
    Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
    PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Changes in Medical Services and Related Costs in a Single Cohort of Patients Newly Diagnosed With Type 2 Diabetes, 2006 to 2012.
    Weng W; Liang Y; Kimball ES; Hobbs T; Kong S; Sakurada B; Bouchard J
    Clin Ther; 2016 Jun; 38(6):1314-1326. PubMed ID: 27129399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system.
    Bahia LR; Araujo DV; Schaan BD; Dib SA; Negrato CA; Leão MP; Ramos AJ; Forti AC; Gomes MB; Foss MC; Monteiro RA; Sartorelli D; Franco LJ
    Value Health; 2011; 14(5 Suppl 1):S137-40. PubMed ID: 21839888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil.
    Rosa MQM; Rosa RDS; Correia MG; Araujo DV; Bahia LR; Toscano CM
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29419786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic Impact of Diabetes in Africa.
    Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
    Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of diabetes mellitus estimated with a longitudinal population-based study using administrative databases.
    Scalone L; Cesana G; Furneri G; Ciampichini R; Beck-Peccoz P; Chiodini V; Mangioni S; Orsi E; Fornari C; Mantovani LG
    PLoS One; 2014; 9(12):e113741. PubMed ID: 25470484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of Osteoporotic Fractures in Singapore.
    Ng CS; Lau TC; Ko Y
    Value Health Reg Issues; 2017 May; 12():27-35. PubMed ID: 28648313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direct medical cost of type 2 diabetes mellitus in South Africa: a cost of illness study.
    Erzse A; Stacey N; Chola L; Tugendhaft A; Freeman M; Hofman K
    Glob Health Action; 2019; 12(1):1636611. PubMed ID: 31282315
    [No Abstract]   [Full Text] [Related]  

  • 14. Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis.
    Cheng SW; Wang CY; Chen JH; Ko Y
    Medicine (Baltimore); 2018 Aug; 97(31):e11602. PubMed ID: 30075532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Impact of Treatment Duration and Persistence with Basal Insulin in Previously Insulin-Naive Users.
    Kalirai S; Duan R; Liu D; Reed BL
    J Manag Care Spec Pharm; 2017 Mar; 23(3):327-336. PubMed ID: 28230446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
    Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifetime cost for type 2 diabetes mellitus in Singapore.
    Ang YG; Yap CW; You AX
    J Diabetes; 2018 Apr; 10(4):296-301. PubMed ID: 28834603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
    Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
    Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Diabetes Treatment-Related Attributes on Costs to Type 2 Diabetes Patients in a Real-World Population.
    Meng J; Casciano R; Lee YC; Stern L; Gultyaev D; Tong L; Kitio-Dschassi B
    J Manag Care Spec Pharm; 2017 Apr; 23(4):446-452. PubMed ID: 28345434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort study.
    Li X; Xu Z; Ji L; Guo L; Liu J; Feng K; Xu Y; Zhu D; Jia W; Ran X; Chen L; Zhao S; Shi B; Zhu J; Shan Z; Zhou Z; Zeng L; Weng J;
    J Diabetes Investig; 2019 Mar; 10(2):539-551. PubMed ID: 30079578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.